These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 39105870)
1. Unlocking the potential of HHLA2: identifying functional immune infiltrating cells in the tumor microenvironment and predicting clinical outcomes in laryngeal squamous cell carcinoma. Li W; You J; Xue H; Liu Y; Chen J; Zheng X; Chen L; Wu C Cancer Immunol Immunother; 2024 Aug; 73(10):207. PubMed ID: 39105870 [TBL] [Abstract][Full Text] [Related]
2. Multiplex immunohistochemistry defines the tumor immune microenvironment and immunotherapeutic outcome in CLDN18.2-positive gastric cancer. Jia K; Chen Y; Sun Y; Hu Y; Jiao L; Ma J; Yuan J; Qi C; Li Y; Gong J; Gao J; Zhang X; Li J; Zhang C; Shen L BMC Med; 2022 Jul; 20(1):223. PubMed ID: 35811317 [TBL] [Abstract][Full Text] [Related]
3. HHLA2 in intrahepatic cholangiocarcinoma: an immune checkpoint with prognostic significance and wider expression compared with PD-L1. Jing CY; Fu YP; Yi Y; Zhang MX; Zheng SS; Huang JL; Gan W; Xu X; Lin JJ; Zhang J; Qiu SJ; Zhang BH J Immunother Cancer; 2019 Mar; 7(1):77. PubMed ID: 30885276 [TBL] [Abstract][Full Text] [Related]
4. Assessment of tumor-associated immune cells in laryngeal squamous cell carcinoma. Zhou L; Li Y; Gao W; Huangfu H; Wen S; Zhang C; Zhao Q; Dong Z; Qu C; Li G; Wu L; Wang B J Cancer Res Clin Oncol; 2019 Jul; 145(7):1761-1772. PubMed ID: 31115672 [TBL] [Abstract][Full Text] [Related]
5. Prognostic Impact of Tumor-Infiltrating Lymphocytes in Laryngeal Squamous Cell Carcinoma Patients. Zhang D; Tang D; Heng Y; Zhu XK; Zhou L; Tao L; Lu LM Laryngoscope; 2021 Apr; 131(4):E1249-E1255. PubMed ID: 33107987 [TBL] [Abstract][Full Text] [Related]
6. Lectin-like Transcript-1 (LLT1) Expression in Oral Squamous Cell Carcinomas: Prognostic Significance and Relationship with the Tumor Immune Microenvironment. de Vicente JC; Lequerica-Fernández P; Rodrigo JP; Rodríguez-Santamarta T; Blanco-Lorenzo V; Prieto-Fernández L; Corte-Torres D; Vallina A; Domínguez-Iglesias F; Álvarez-Teijeiro S; García-Pedrero JM Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673902 [TBL] [Abstract][Full Text] [Related]
7. Analysis of tumor-infiltrating CD103 resident memory T-cell content in recurrent laryngeal squamous cell carcinoma. Mann JE; Smith JD; Birkeland AC; Bellile E; Swiecicki P; Mierzwa M; Chinn SB; Shuman AG; Malloy KM; Casper KA; McLean SA; Moyer JS; Wolf GT; Bradford CR; Prince ME; Carey TE; McHugh JB; Spector ME; Brenner JC Cancer Immunol Immunother; 2019 Feb; 68(2):213-220. PubMed ID: 30361882 [TBL] [Abstract][Full Text] [Related]
9. CD206 Heng Y; Zhu X; Lin H; Jingyu M; Ding X; Tao L; Lu L J Transl Med; 2023 Mar; 21(1):167. PubMed ID: 36864443 [TBL] [Abstract][Full Text] [Related]
10. Immune cell infiltration as an indicator of the immune microenvironment of pancreatic cancer. Ino Y; Yamazaki-Itoh R; Shimada K; Iwasaki M; Kosuge T; Kanai Y; Hiraoka N Br J Cancer; 2013 Mar; 108(4):914-23. PubMed ID: 23385730 [TBL] [Abstract][Full Text] [Related]
11. Prognostic values of B7-H3, B7-H4, and HHLA2 expression in human pancreatic cancer tissues based on mIHC and spatial distribution analysis. Zhu Y; Chen J; Liu Y; Zheng X; Feng J; Chen X; Jiang T; Li Y; Chen L Pathol Res Pract; 2022 Jun; 234():153911. PubMed ID: 35489125 [TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of tumor infiltrating immune cells in oral squamous cell carcinoma. Fang J; Li X; Ma D; Liu X; Chen Y; Wang Y; Lui VWY; Xia J; Cheng B; Wang Z BMC Cancer; 2017 May; 17(1):375. PubMed ID: 28549420 [TBL] [Abstract][Full Text] [Related]
13. Prognostic impact of immune microenvironment in laryngeal and pharyngeal squamous cell carcinoma: Immune cell subtypes, immuno-suppressive pathways and clinicopathologic characteristics. Karpathiou G; Casteillo F; Giroult JB; Forest F; Fournel P; Monaya A; Froudarakis M; Dumollard JM; Prades JM; Peoc'h M Oncotarget; 2017 Mar; 8(12):19310-19322. PubMed ID: 28038471 [TBL] [Abstract][Full Text] [Related]
14. APE1 facilitates PD-L1-mediated progression of laryngeal and hypopharyngeal squamous cell carcinoma. Wang J; Lun L; Jiang X; Wang Y; Li X; Du G; Wang J Int Immunopharmacol; 2021 Aug; 97():107675. PubMed ID: 33964809 [TBL] [Abstract][Full Text] [Related]
16. Prognostic and clinicopathological significance of PD-L1 and tumor infiltrating lymphocytes in hypopharyngeal squamous cell carcinoma. Hu C; Tian S; Lin L; Zhang J; Ding H Oral Oncol; 2020 Mar; 102():104560. PubMed ID: 31923855 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of PD-L1 Expression and Associated Tumor-Infiltrating Lymphocytes in Laryngeal Squamous Cell Carcinoma. Vassilakopoulou M; Avgeris M; Velcheti V; Kotoula V; Rampias T; Chatzopoulos K; Perisanidis C; Kontos CK; Giotakis AI; Scorilas A; Rimm D; Sasaki C; Fountzilas G; Psyrri A Clin Cancer Res; 2016 Feb; 22(3):704-13. PubMed ID: 26408403 [TBL] [Abstract][Full Text] [Related]
18. B7 score and T cell infiltration stratify immune status in prostate cancer. Zhou Q; Li K; Lai Y; Yao K; Wang Q; Zhan X; Peng S; Cai W; Yao W; Zang X; Xu K; Huang J; Huang H J Immunother Cancer; 2021 Aug; 9(8):. PubMed ID: 34417325 [TBL] [Abstract][Full Text] [Related]
19. Tumor Infiltrating Lymphocytes and CD8+ T Cell Subsets as Prognostic Markers in Patients with Surgically Treated Laryngeal Squamous Cell Carcinoma. Chatzopoulos K; Kotoula V; Manoussou K; Markou K; Vlachtsis K; Angouridakis N; Nikolaou A; Vassilakopoulou M; Psyrri A; Fountzilas G Head Neck Pathol; 2020 Sep; 14(3):689-700. PubMed ID: 31749124 [TBL] [Abstract][Full Text] [Related]
20. Proportion of CD4 and CD8 tumor infiltrating lymphocytes predicts survival in persistent/recurrent laryngeal squamous cell carcinoma. Hoesli R; Birkeland AC; Rosko AJ; Issa M; Chow KL; Michmerhuizen NL; Mann JE; Chinn SB; Shuman AG; Prince ME; Wolf GT; Bradford CR; McHugh JB; Brenner JC; Spector ME Oral Oncol; 2018 Feb; 77():83-89. PubMed ID: 29362129 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]